REN and hydrops fetalis: Blockade of the renin–angiotensin–aldosterone system (RAAS) is the central treatment for HF with decreased EF utilizing agents such as angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, with or without renin–angiotensin–aldosterone system angiotensin neprilysin inhibitors.